BIOMAT Database Logo BIOMAT Database Logo

One year booster vaccination with purified vero cell rabies vaccine. 1988

P Suntharasamai, and P Chanthavanich, and W Supanaranond, and M J Warrell
Hospital of Tropical Diseases, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.

UI MeSH Term Description Entries
D007117 Immunization, Secondary Any immunization following a primary immunization and involving exposure to the same or a closely related antigen. Immunization, Booster,Revaccination,Secondary Immunization,Booster Immunization,Booster Immunizations,Immunizations, Booster,Immunizations, Secondary,Revaccinations,Secondary Immunizations
D011818 Rabies Acute VIRAL CNS INFECTION affecting mammals, including humans. It is caused by RABIES VIRUS and usually spread by contamination with virus-laden saliva of bites inflicted by rabid animals. Important animal vectors include the dog, cat, bat, fox, raccoon, skunk, and wolf. Encephalitic Rabies,Furious Rabies,Hydrophobia,Paralytic Rabies,Lyssa,Furious Raby,Lyssas,Rabies, Encephalitic,Rabies, Furious,Raby, Furious
D011819 Rabies Vaccines Vaccines or candidate vaccines used to prevent and treat RABIES. The inactivated virus vaccine is used for preexposure immunization to persons at high risk of exposure, and in conjunction with rabies immunoglobulin, for postexposure prophylaxis. Rabies Human Diploid Cell Vaccine,Rabies Vaccine,Vaccine, Rabies,Vaccines, Rabies
D011820 Rabies virus The type species of LYSSAVIRUS causing rabies in humans and other animals. Transmission is mostly by animal bites through saliva. The virus is neurotropic multiplying in neurons and myotubes of vertebrates. Rabies viruses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D014709 Vero Cells A CELL LINE derived from the kidney of the African green (vervet) monkey, (CHLOROCEBUS AETHIOPS) used primarily in virus replication studies and plaque assays. Cell, Vero,Cells, Vero,Vero Cell

Related Publications

P Suntharasamai, and P Chanthavanich, and W Supanaranond, and M J Warrell
Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine.
January 2000, Bulletin of the World Health Organization,
P Suntharasamai, and P Chanthavanich, and W Supanaranond, and M J Warrell
Immunogenicity and safety in adults of a new chromatographically purified Vero-cell rabies vaccine (CPRV): a randomized, double-blind trial with purified Vero-cell rabies vaccine (PVRV).
December 1998, Biologicals : journal of the International Association of Biological Standardization,
P Suntharasamai, and P Chanthavanich, and W Supanaranond, and M J Warrell
Acceptability and efficacy of purified vero-cell rabies vaccine in Thai children exposed to rabies.
January 1988, Asia-Pacific journal of public health,
P Suntharasamai, and P Chanthavanich, and W Supanaranond, and M J Warrell
Persistence of antibodies in children after intradermal or intramuscular administration of preexposure primary and booster immunizations with purified Vero cell rabies vaccine.
November 1998, The Pediatric infectious disease journal,
P Suntharasamai, and P Chanthavanich, and W Supanaranond, and M J Warrell
Post-exposure prophylaxis with purified vero cell rabies vaccine during pregnancy--safety and immunogenicity.
December 1999, The Journal of communicable diseases,
P Suntharasamai, and P Chanthavanich, and W Supanaranond, and M J Warrell
Booster effect of a new chromatographically purified Vero-cell rabies vaccine (CPRV): immunogenicity and safety of a single or double injection.
January 2001, Transactions of the Royal Society of Tropical Medicine and Hygiene,
P Suntharasamai, and P Chanthavanich, and W Supanaranond, and M J Warrell
Immunogenicity and safety of purified Vero-cell rabies vaccine in severely rabies-exposed patients in China.
June 2000, The Southeast Asian journal of tropical medicine and public health,
P Suntharasamai, and P Chanthavanich, and W Supanaranond, and M J Warrell
Three-year experience with 4-site intradermal booster vaccination with rabies vaccine for postexposure prophylaxis.
December 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
P Suntharasamai, and P Chanthavanich, and W Supanaranond, and M J Warrell
Protecting Indian schoolchildren against rabies: pre-exposure vaccination with purified chick embryo cell vaccine (PCECV) or purified verocell rabies vaccine (PVRV).
January 2008, Human vaccines,
P Suntharasamai, and P Chanthavanich, and W Supanaranond, and M J Warrell
The immunogenicity and safety of vaccination with purified Vero cell rabies vaccine (PVRV) in China under a 2-1-1 regimen.
February 2011, Human vaccines,
Copied contents to your clipboard!